首页> 美国卫生研究院文献>Cancer Medicine >Distribution and role of high‐risk human papillomavirus genotypes in women with cervical intraepithelial neoplasia: A retrospective analysis from Wenzhou southeast China
【2h】

Distribution and role of high‐risk human papillomavirus genotypes in women with cervical intraepithelial neoplasia: A retrospective analysis from Wenzhou southeast China

机译:高危型人乳头瘤病毒基因型在宫颈上皮内瘤变妇女中的分布及其作用:来自中国东南部温州的回顾性分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

To add the growing literature on baseline of high‐risk human papillomavirus (HR‐HPV) genotype distribution in cervical intraepithelial neoplasia (CIN) before the widespread using of HPV vaccines in Chinese mainland and to improve risk stratification of HR‐HPV–positive women. Retrospectively, the data of age, cervical HPV genotypes, cytology, and pathology were collected from 1166 patients who received loop electrosurgical excision procedure (LEEP). HPV genotypes were analyzed with Flowcytometry Fluorescence Hybridization Method. And then HPV prevalence, HR‐HPV genotype distribution and the correlation of HR‐HPV genotypes with CIN2+ (CIN2 or severer) were analyzed. The role of multiple style="fixed-case">HR‐ style="fixed-case">HPV types infection with or without style="fixed-case">HPV16/18 in the pathogenesis of style="fixed-case">CIN2+ was also analyzed. The 6 most common style="fixed-case">HR‐ style="fixed-case">HPV genotypes were style="fixed-case">HPV16, 58, 52, 33, 18, and 31 in descending order. Compared to style="fixed-case">HR‐ style="fixed-case">HPV–negative women, style="fixed-case">HPV16, 33 or 58 positive women had higher risk of style="fixed-case">CIN2+ ( style="fixed-case">OR = 5.10, 95% style="fixed-case">CI = 2.68‐9.70; style="fixed-case">OR = 3.09, 95% style="fixed-case">CI = 1.39‐6.84; style="fixed-case">OR = 3.57, 95% style="fixed-case">CI = 1.85‐6.89, respectively). And women who were infected by multiple style="fixed-case">HR‐ style="fixed-case">HPV types infection with style="fixed-case">HPV16/18 also had higher risk of style="fixed-case">CIN2+ ( style="fixed-case">OR = 2.58, 95% style="fixed-case">CI = 1.35‐4.92). However, multiple style="fixed-case">HR‐ style="fixed-case">HPV types infection without style="fixed-case">HPV16/18 did not increase the risk significantly (P = .08). Compare to bivalent Cervarix® and quadrivalent Gardasil®, style="fixed-case">HPV prophylactic vaccine targeting style="fixed-case">HPV31, 33, 52, and 58 might provide women more protection from style="fixed-case">HPV‐induced cervical cancer in China. The women who infected by style="fixed-case">HPV16, 33, 58, or multiple style="fixed-case">HR‐ style="fixed-case">HPV types with style="fixed-case">HPV16/18 have higher risk of style="fixed-case">CIN2+ and need to be paid more attention in screening processes. And the role of multiple style="fixed-case">HR‐ style="fixed-case">HPV types infection without style="fixed-case">HPV16/18 needs be further identified in more studies.
机译:在中国大陆广泛使用HPV疫苗之前,增加关于宫颈上皮内瘤变(CIN)中高危型人乳头瘤病毒(HR-HPV)基因型分布基线的增长文献,并改善HR-HPV阳性女性的风险分层。回顾性分析年龄,宫颈HPV基因型,细胞学和病理学资料,这些资料来自1166例接受环行电外科切除术(LEEP)的患者。用流式细胞术荧光杂交法分析HPV基因型。然后分析了HPV患病率,HR-HPV基因型分布以及HR-HPV基因型与CIN2 +(CIN2或更严重)的相关性。多种 style =“ fixed-case”> HR - style =“ fixed-case”> HPV 类型感染在有或没有 style =“ fixed-case”>的情况下的作用还分析了HPV 16/18在 style =“ fixed-case”> CIN 2+发病中的作用。 6种最常见的 style =“ fixed-case”> HR - span style =“ fixed-case”> HPV 基因型是 style =“ fixed-case”> HPV 16、58、52、33、18和31降序排列。与 style =“ fixed-case”> HR - style =“ fixed-case”> HPV –阴性女性相比, style =“ fixed-case”> HPV span> 16、33或58位阳性女性患 style =“ fixed-case”> CIN 2+的风险较高( style =“ fixed-case”> OR = 5.10,95 % style =“ fixed-case”> CI = 2.68-9.70; style =“ fixed-case”> OR = 3.09,95% style =“ fixed-case” > CI = 1.39-6.84; style =“ fixed-case”> OR = 3.57,95% style =“ fixed-case”> CI = 1.85-6.89 , 分别)。感染了多种 style =“ fixed-case”> HR - style =“ fixed-case”> HPV 的女性会感染 style =“ fixed-case” > HPV 16/18也有较高的 style =“ fixed-case”> CIN 2+( style =“ fixed-case”> OR = 2.58, 95% style =“ fixed-case”> CI = 1.35-4.92)。但是,多个 style =“ fixed-case”> HR - style =“ fixed-case”> HPV 类型的感染没有 style =“ fixed-case”> HPV 16/18并没有显着增加风险(P = .08)。与二价Cervarix ®和四价Gardasil ®相比, style =“ fixed-case”> HPV 预防性疫苗靶向 style =“ fixed-case “> HPV 31、33、52和58可能会为女性提供更多保护,使其免受中国由 style =” fixed-case“> HPV 诱发的宫颈癌的侵害。感染了 style =“ fixed-case”> HPV 16、33、58或多个 style =“ fixed-case”> HR - style =“ fixed -case“> HPV 类型为 style =” fixed-case“> HPV 16/18的 style =” fixed-case“> CIN 2+的风险较高在筛选过程中需要引起更多关注。多种 style =“ fixed-case”> HR - span style =“ fixed-case”> HPV 类型的感染不会感染 style =“ fixed-case”> HPV 16/18需要在更多研究中进一步确定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号